ARE YOU REALLY READY FOR CLINICAL TRIAL MANUFACTURING?
Most R&D teams think they're GMP-ready — until they're not.
The move from R&D into clinical trial manufacturing - making a GMP product for use in a clinical trial - is one of the highest-risk transitions a growing biotech or pharma company makes. The science that got a product through development doesn't automatically come with a GMP-compliant manufacturing system attached — and the gap between "we can make this in the lab" and "we can manufacture this under GMP, for a trial, with a sponsor's name on it" is where most R&D teams get caught out.
The risks aren't limited to your own systems. Supplier and vendor oversight, sponsor compliance obligations, GCP requirements and phase-appropriate PQS expectations all land at once during this transition — and regulators alike expect them handled before batch one ships.
The Clinical Trial Manufacturing Readiness Scorecard is a free, 21-question self-assessment built to catch exactly these gaps — GMP manufacturing readiness, supplier risk, quality documentation and sponsor/GCP obligations — before they become a regulatory issue or a delayed trial.
What You Will Learn
Whether your PQS processes and documentation meet GMP expectations for clinical trial supply, not just R&D-stage practice
Where your supplier and vendor oversight has gaps that could expose your trial to risk
Whether your PQS is phase-appropriate for a clinical-stage company, or built for a stage you've already outgrown
How ready you are to meet sponsor compliance and GCP obligations as clinical biotech contracting GMP manufacturing
A readiness score and practical next steps to move into clinical manufacturing with confidence
Who Is This Scorecard For?
R&D teams and biotechs transitioning from development into clinical trial manufacturing
Companies about to engage — or already working with — a CDMO or contract manufacturer for trial supply
Quality and regulatory leads responsible for sponsor compliance and GCP obligations ahead of a trial
Growing companies without a dedicated GMP compliance resource making this transition for the first time
Why This Scorecard, Why QSN?
QSN works with R&D and clinical-stage companies specifically on this transition — GMP manufacturing readiness, supplier assurance, phase-appropriate PQS design, and sponsor/GCP compliance support. The scorecard is built from that experience, not a generic GMP checklist applied to a clinical-trial context.
QSN's phase-appropriate philosophy matters most here: an early-stage clinical manufacturer doesn't need an enterprise GMP system, it needs the right-sized one for where it actually is — over-engineering at this stage costs time and budget a growing company can't spare.
What Happens After You Complete It?
You'll get a Readiness Score across manufacturing, supplier oversight, PQS and sponsor/GCP compliance, plus practical next steps — no fluff, no spam, just a clear read on where the gaps are before your next batch or your next sponsor audit. Reach out to us if you need support in this transition by booking a free, no obligation, consulting call.
